Revance Therapeutics, Inc. (RVNC)
NASDAQ: RVNC · IEX Real-Time Price · USD
3.960
-0.290 (-6.82%)
At close: Jul 17, 2024, 4:00 PM
3.950
-0.010 (-0.25%)
After-hours: Jul 17, 2024, 7:32 PM EDT

Revance Therapeutics Stock Forecast

Stock Price Forecast

The 9 analysts with 12-month price forecasts for RVNC stock have an average target of 12, with a low estimate of 8.00 and a high estimate of 20. The average target predicts an increase of 203.03% from the current stock price of 3.96.

Analyst Consensus: Buy
Target Low Average Median High
Price $8.00 $12 $11 $20
Change +102.02% +203.03% +177.78% +405.05%
* Price targets were last updated on May 13, 2024.

Analyst Ratings

The average analyst rating for RVNC stock from 9 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Feb '24Mar '24Apr '24May '24Jun '24Jul '24
Strong Buy 333333
Buy 222222
Hold 444444
Sell 000000
Strong Sell 000000
Total 999999

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$12$11
Strong Buy Maintains $12$11 +177.78% May 13, 2024
Goldman Sachs
Goldman Sachs
Hold
Maintains
$9$8
Hold Maintains $9$8 +102.02% May 13, 2024
Piper Sandler
Piper Sandler
Buy
Reiterates
$20$11
Buy Reiterates $20$11 +177.78% May 10, 2024
Mizuho
Mizuho
Hold
Maintains
$9$8
Hold Maintains $9$8 +102.02% May 10, 2024
Needham
Needham
Strong Buy
Maintains
$18$12
Strong Buy Maintains $18$12 +203.03% May 10, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
282.33M
from 234.04M
Increased by 20.63%
Revenue Next Year
380.58M
from 282.33M
Increased by 34.80%
EPS This Year
-2.14
from -3.83
EPS Next Year
-0.90
from -2.14
Year 2019202020212022202320242025202620272028
Revenue
413.00K15.33M77.80M132.57M234.04M282.33M380.58M485.27M607.97M738.94M
Revenue Growth
-88.92%3,610.65%407.65%70.40%76.55%20.63%34.80%27.51%25.28%21.54%
EPS
-3.67-4.86-4.17-4.90-3.83-2.14-0.90-0.150.781.36
EPS Growth
---------75.12%
Forward PE
--------5.092.90
No. Analysts -----14141355
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 300.9M 437.3M 570.8M 763.9M 893.8M
Avg 282.3M 380.6M 485.3M 608.0M 738.9M
Low 262.4M 332.3M 399.1M 471.6M 549.3M

Revenue Growth

Revenue Growth 20242025202620272028
High
28.6%
54.9%
50.0%
57.4%
47.0%
Avg
20.6%
34.8%
27.5%
25.3%
21.5%
Low
12.1%
17.7%
4.9%
-2.8%
-9.7%

EPS Forecast

EPS 20242025202620272028
High -1.52 -0.61 0.35 1.41 1.73
Avg -2.14 -0.90 -0.15 0.78 1.36
Low -3.32 -1.27 -0.74 0.44 0.94

EPS Growth

EPS Growth 20242025202620272028
High - - - -
122.5%
Avg - - - -
75.1%
Low - - - -
20.8%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.